American College Of Surgeons - Inspiring Quality: Highest Standards, Better Outcomes

Session Code: PS108
Title: Management of the Axilla in Breast Cancer
Date and Time of Session: Monday, October 23: 11:30 am - 1:00 pm
Description: The management of the axilla for breast cancer in both the primary surgical and neoadjuvant setting has been changing with the recent publication of large, randomized trials. This session will present data from the Z0011 trial for how to manage the axilla in patients whose primary treatment is breast conserving surgery, specifically who can avoid a completion axillary dissection. In addition the management of the axilla in patients undergoing mastectomy as primary surgery will be addressed. For patients undergoing neoadjuvant chemotherapy, the data from Z1071 will be presented to address issues such as the false negative rate of sentinel node biopsy in this population and how to manage residual nodal disease.
CME Credit Hours: 1.5
Webcast Package Available: Yes
Audio Package Available: Yes
Track:
Surgical Oncology (ONC), Obstetrics and Gynecology (OBG)
Credit to Address ACS Accreditation/Verification Requirements:
Breast, Cancer
Sponsored By:
Commission on Cancer, CRP Education Committee
Program Participants:
Moderator
Laurie Jill Kirstein, MD FACS
Co-Moderator
Judy C. Boughey, MB, BChir, FACS
Speaker Management of the Axilla in Patients Undergoing Lumpectomy with a Positive Sentinel Lymph Node (SLN) - Armando Giuliano Questions
Armando E. Giuliano, MD, FACS, FRCSEd
Speaker Management of the Axilla in Patients Undergoing Mastectomy with a Positive Sentinel Lymph Node (SLN)
Elizabeth A. Mittendorf, MD, PhD, FACS
Speaker Management of the Axilla in Node Positive Patients treated with Neoadjuvant Chemotherapy
Judy C. Boughey, MB, BChir, FACS